ISSN Print 2713-0894    ISSN Online 2713-0908
Medical Ethics
BIOMEDICAL JOURNAL OF ERMC EASTERN EUROPEAN

Evgeniy I GUSEV

ORCID: 0000-0003-0742-6875

Scopus Author ID: 35599379800

RSCI Author ID: 91278

Head of the Department of Neurology, Neurosurgery and Medical Genetics, Faculty of General Medicine, Pirogov Russian National Research Medical University (Moscow, Russia).

Member of RAS, DSc (medicine), professor

Areas of expertise:

Vascular disorders of the brain, demyelinating diseases, hereditary disorders of the nervous system, epilepsy.

Special awards and honors:

Honored Scientist of the Russian Federation.

Significant publications in last 5 years

  1. Kvetkovskaya AA, Evseveva ME, Martynov MYu, Gusev EI. [Characteristics of risk factors in young and middle-aged patients with first hemispheric ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115 (12–2): 13–8. Russian.
  2. Popova EV, Korobko DS, Bulatova EV, Melnikova AA, Babenko LA, Sazonov DS, Boyko AN, Malkova NA, Sivertseva SA, Gusev EI. [A retrospective analysis of the effect of pregnancy on the course of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115 (8–2): 18–21. Russian.
  3. Gusev EI, Chukanova EI. [Modern pathogenetic aspects of development of cerebral chronic ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115 (3): 4–8. Russian.
  4. Abakumova TO, Nukolova NV, Gusev EI, Chekhonin VP. [Contrast agents in MRI-diagnosis of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115 (1): 58–65. Russian.
  5. Kulakova OG, Tsareva EY, Boyko AN, Gusev EI, Favorova OO, Shchur SG, et al. Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients. Pharmacogenomics. 2012; 13 (15): 1689–1700. DOI: 10.2217/pgs.12.161.
  6. Petrova LV, Boiko AN, Gusev EI, Batysheva TT. Possible Effect of Immunomodulatory Treatment on the Development of Thyroid Gland Pathology in Patients with Multiple Sclerosis. Neurosci Behav Physi. 2012; 42: 327. DOI: 10.1007/s11055-012-9571-5.
  7. Davydovskaya MV, Boiko AN, Gusev EI, Podoprigora AE, Pronin IN, Kornienko VN. [Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of β-interferon 1a (avonex)]. Zh Nevrol Psikhiatr Im S S Korsakova. 2012; 112 (9–2): 129–35. Russian.
  8. Martynov MY, Boiko AN, Kamchatnov PR, Kabanov AA, Yasamanova AN, Shchukin IA, Kolesnikova TI, Chubykin VI, Glukhareva AP, Gusev EI. [Neuroprotective treatment with citicoline (ceraxon) in patients with ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2012; 112 (3–2): 21–6. Russian.
  9. Titov BV, Barsova RM, Martynov MYu, Nikonova AA, Gusev EI, Favorova OO, et al. Polymorphic variants of the genes encoding intrleukin-6 and fibrinogen: risk for ischemic stroke and fibrinogen levels. Molecular Biology. 2012; 46 (1): 85–93.
  10. Tsareva EY, Kulakova OG, Boyko AN, Gusev EI, Favorova OO, Shchur SG, et al. Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients. Pharmacogenomics. 2012; 13 (1): 43–53. DOI: 10.2217/pgs.11.136.